ONCT - Oncternal Therapeutics Inc. (ONCT) CEO James Breitmeyer on Q1 2022 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc (ONCT) Q1 2022 Earnings Conference Call May 5, 2022, 5:00 PM ET Company Participants James Breitmeyer – President & Chief Executive Officer Richard Vincent – Chief Financial Officer Salim Yazji – Chief Medical Officer Conference Call Participants Hartaj Singh – Oppenheimer Carl Byrnes – Northland Capital Markets Brian Petitt – BTIG Investment Banking Shubhendu Sen Roy – Brookline Capital Markets Presentation Operator Greetings and welcome to Oncternal Therapeutics, Inc Third Quarter 2022 Financial Results Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] It is now my pleasure to introduce your host, Richard Vincent, Chief Financial Officer. Thank you. You may begin. Richard Vincent Thank you, Doug. Good afternoon, everyone, and thank you for joining us today as we cover our First Quarter 2022 earnings. Joining me on the call this afternoon are our President
For further details see:
Oncternal Therapeutics, Inc. (ONCT) CEO James Breitmeyer on Q1 2022 Results - Earnings Call Transcript